The Rwanda Food and Drugs Authority (Rwanda FDA) has issued a circular requiring all Marketing Authorization Holders (MAHs) with medicinal products registered and marketed in Rwanda to appoint a Qualified Person for Pharmacovigilance (QPPV).

This regulatory development marks a significant step in strengthening the country's pharmacovigilance system and ensuring the continuous monitoring of the safety, quality, and effectiveness of medicinal products throughout their lifecycle.

What Does This Mean for Marketing Authorization Holders?

Under the new requirement, MAHs are expected to designate a suitably qualified individual who will be responsible for overseeing pharmacovigilance activities, ensuring compliance with local regulatory obligations, and serving as the primary contact person for safety-related communications with the Rwanda FDA.

Key responsibilities of the QPPV typically include:

•    Establishing and maintaining an effective pharmacovigilance system
•    Monitoring and evaluating adverse drug reactions and other safety information.
•    Ensuring timely submission of safety reports to regulatory authorities.
•    Maintaining pharmacovigilance documentation and records.
•    Supporting regulatory inspections and audits.

Failure to comply with pharmacovigilance requirements may expose MAHs to regulatory actions and potential risks to product continuity in the market.

Preparing for Compliance

Companies that have not yet established local pharmacovigilance oversight should begin assessing their readiness to meet the new requirements. This includes reviewing existing pharmacovigilance systems, SOPs, safety reporting processes, and QPPV appointment arrangements.

Early preparation will help ensure uninterrupted compliance and demonstrate commitment to patient safety and regulatory excellence.

How Regulix Consultancy Can Help

Regulix Consultancy provides comprehensive pharmacovigilance support services to pharmaceutical companies operating across Africa, including:

•    QPPV and Local Safety Officer services
•    Pharmacovigilance system setup and maintenance
•    Development of PV SOPs and Quality Management Systems
•    PSMF preparation and maintenance
•    Adverse event case processing and reporting
•    Pharmacovigilance training and compliance support

Contact Us Today

If your organization markets medicinal products in Rwanda and requires support with QPPV appointment or pharmacovigilance compliance, our team is ready to assist.

Contact Regulix Consultancy today to discuss your pharmacovigilance requirements and ensure full compliance with Rwanda FDA regulations.